Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.92 is 62% below its 5-year average of 7.74, near the low end of its 5-year range (2.46–32.03).
As of the fiscal period ended Tuesday, June 30, 2026. 5.73% below its 12-month average of 3.09.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.92.
CURRENT RATIO
2.92
CURRENT RATIO AVG TTM
3.09
CURRENT RATIO AVG 3Y
5.09
CURRENT RATIO AVG 5Y
7.74
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.73%
CURRENT VS 3Y AVG
-42.73%
CURRENT VS 5Y AVG
-62.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
-18.87%
vs the sector median at left
Arcutis Biotherapeutics, Inc.
Market Cap
$3.06B
Current Ratio
2.92
TTM Avg
3.09
3Y Avg
5.09
5Y Avg
7.74
Market Cap
$3.06B
Current Ratio
64.07
TTM Avg
24.32
3Y Avg
16.73
5Y Avg
16.77
Market Cap
$3.07B
Current Ratio
12.12
TTM Avg
10.47
3Y Avg
8.70
5Y Avg
7.11
Market Cap
$2.88B
Current Ratio
12.02
TTM Avg
18.93
3Y Avg
12.46
5Y Avg
15.83
Market Cap
$3.34B
Current Ratio
17.91
TTM Avg
1.68
3Y Avg
1.68
5Y Avg
1.68
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.06B | 2.92 | 3.09 | 5.09 | 7.74 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.06B | 64.07 | 24.32 | 16.73 | 16.77 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.07B | 12.12 | 10.47 | 8.70 | 7.11 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.13B | 8.37 | 8.81 | 8.76 | 9.71 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 12.02 | 18.93 | 12.46 | 15.83 |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 6.62 | 7.72 | 8.85 | 8.81 |
| AtriCure, Inc. (ATRC)vs › | $2.80B | 4.22 | 3.80 | 3.72 | 4.10 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.34B | 17.91 | 1.68 | 1.68 | 1.68 |
| CareDx, Inc (CDNA)vs › | $3.38B | 4.58 | 3.40 | 3.98 | 4.25 |
| Precigen, Inc. (PGEN)vs › | $2.72B | 4.58 | 3.92 | 3.08 | 3.40 |
Current Ratio
2.92
Quick Ratio
2.67
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.92 |
| 2026-03-31 | 2.68 |
| 2025-12-31 | 3.17 |
| 2025-09-30 | 3.50 |
| 2025-06-30 | 3.20 |
| 2025-03-31 | 3.55 |
| 2024-12-31 | 4.15 |
| 2024-09-30 | 2.46 |
| 2024-06-30 | 8.46 |
| 2024-03-31 | 9.89 |
| 2023-12-31 | 7.08 |
| 2023-09-30 | 6.72 |
| 2023-06-30 | 8.43 |
| 2023-03-31 | 9.93 |
| 2022-12-31 | 11.57 |
| 2022-09-30 | 13.39 |
| 2022-06-30 | 10.75 |
| 2022-03-31 | 10.89 |
| 2021-12-31 | 12.09 |
| 2021-09-30 | 20.03 |
| 2021-06-30 | 32.03 |
| 2021-03-31 | 30.43 |
| 2020-12-31 | 12.96 |
| 2020-09-30 | 9.18 |
| 2020-06-30 | 11.83 |
| 2020-03-31 | 20.77 |
| 2019-12-31 | 20.33 |
| 2019-09-30 | 3.23 |
| 2019-06-30 | 9.02 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 19.12 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
